drugset / Trial / NCT05173090
Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.
RandomizedParallel-groupSingle-blindTreatment
Summary
Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.
Timeline
- Start
- 2022-01-15
- Primary completion
- 2022-06-30
- Completion
- 2022-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ropivacaine | Other / unclassified | 3 mg/kg | Other |
Indications
No indication recorded.